Alison Moore Net Worth & Insider Trades

Alison Moore - Chief Technical Officer, Allogene Therapeutics, Inc

As of March 25, 2022

What is Alison Moore's Net Worth?

The current estimated net worth of Allogene Therapeutics, Inc's Chief Technical Officer, Alison Moore, is estimated to be about $10.51M . Alison Moore owns about 120,430 units of Allogene Therapeutics, Inc common stock. In the last 3 years at Allogene Therapeutics, Inc, Alison Moore has sold an estimated value of $9.78M worth.

What is Alison Moore's Past Insider Trading?

Alison Moore's largest purchase order was 48,828 units , worth over $110.84K on June 5, 2019. Alison Moore's largest sale order was 44,574 units , worth over $1.83M on October 9, 2020. In total, Alison Moore has made about 15 transactions over 3 years of their time at Allogene Therapeutics, Inc. Alison Moore usually trades in March, with the busiest year in 2020. The most recent transaction was a sale order of 8,698 units , worth over $66.39K on March 17, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Alison Moore's Salary in 2020?

As Chief Technical Officer of Allogene Therapeutics, Inc, Alison Moore has a total base salary of $440,000 . Alison Moore received compensation valued at about $2,483,819 in 2020 after becoming Chief Technical Officer. The vast majority of their compensation came in the form of stock awards of $561,176 , option awards of $1,262,643 , other earnings, plans or compensations of $220,000 , and

What is Alison Moore's' Mailing Address?

  • Mailing address is C/o Allogene Therapeutics, Inc. 210 East Grand Avenue South San Francisco CA 94080 CA

Allogene Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
David Chang, M.D., Ph.D. 2020 $675,000 - - $6,550,535 $506,250 $83,256 $7,815,041
David Chang, M.D., Ph.D. 2019 $600,000 - $4,651,970 $5,327,140 $363,000 $250,000 $11,192,110
David Chang, M.D., Ph.D. 2018 $362,413 - $8,948,152 $3,070,331 $217,641 $250,000 $12,848,537
Eric Schmidt, Ph.D. 2020 $440,000 - $561,176 $1,262,643 $220,000 - $2,483,819
Eric Schmidt, Ph.D. 2019 $425,000 - $1,328,366 $1,519,700 $187,000 - $3,460,066
Eric Schmidt, Ph.D. 2018 $201,232 - - $2,299,658 $88,099 - $2,588,989
Rafael Amado, M.D. 2020 $510,000 $75,000 $561,176 $1,262,643 $255,000 - $2,663,819
Rafael Amado, M.D. 2019 $145,833 - $4,249,976 $2,759,623 $71,726 $225,000 $7,452,158
Alison Moore, Ph.D. 2020 $440,000 - $561,176 $1,262,643 $220,000 - $2,483,819
Alison Moore, Ph.D. 2019 $425,000 - $996,275 $1,519,700 $187,000 - $3,127,975
Alison Moore, Ph.D. 2018 $233,265 - - $1,401,225 $102,124 $100,000 $1,836,614
Veer Bhavnagri 2020 $425,000 - $537,490 $1,211,953 $212,500 $9,385 $2,396,328
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1737287/000173728721000013/allo-20210423xdef14axproxy.htm

What are Allogene Therapeutics, Inc's Past Insider Trades?

Allogene Therapeutics, Inc's most recent insider trade came on August 15, 2022 by Owen Witte who sold 15,000 units worth $251.25K . In the last 4 years, insiders at Allogene Therapeutics, Inc have sold an estimated value of $152.31M and bought an estimated value of $33.14M worth of shares. Insider trading is most common in March, with the busiest year in 2020. The most active traders at the company are David D Chang, President and CEO,  Veer Bhavnagri, General Counsel,  and Alison Moore, Chief Technical Officer .

Allogene Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1